.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Oncologists frequently utilize 5-fluorouracil (5-FU) to treat various solid tumors because of its efficacy. However, its clinical application remains limited by significant side effects, most notably hepatotoxicity. Recent studies indicate that Boldine for 5-FU hepatotoxicity could serve as a promising protective agent by modulating antioxidant pathways. Therefore, researchers have evaluated the potential of boldine, a natural aporphine alkaloid, in mitigating this chemotherapy-induced liver injury.
Boldine demonstrates remarkable antioxidant and anti-inflammatory properties. In addition, this compound specifically activates the Nrf2/ARE signaling pathway in liver tissues. This activation subsequently boosts the expression of essential antioxidant genes like NQO1 and HO-1. Furthermore, boldine treatment effectively lowers serum transaminases, which typically spike during acute hepatocellular injury. Consequently, boldine helps maintain the redox balance within the liver cells.
Moreover, 5-FU administration usually suppresses Nrf2 mRNA expression while increasing markers of inflammation such as NF-κB and ASK1. Conversely, boldine therapy reverses these biochemical alterations. In addition, it enhances dihydropyrimidine dehydrogenase expression, an enzyme critical for the metabolism of 5-FU. As a result, these combined actions ameliorate histopathological damage and restore overall hepatic function. Overall, these findings highlight boldine as a potential adjuvant to reduce the toxic burden of chemotherapy.
Boldine protects the liver by activating the Nrf2/ARE signaling pathway. This process increases the production of antioxidant enzymes and reduces the oxidative stress and inflammation caused by 5-fluorouracil. Furthermore, it helps regulate the metabolism of the drug itself.
In studies, boldine effectively reduces elevated serum transaminases like ALT and AST. It also suppresses inflammatory markers such as NF-κB and increases the expression of cytoprotective antioxidant genes like HO-1 and NQO1.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study shows boldine protects against 5-FU-induced liver injury by activating Nrf2/ARE pathways and reducing oxidative stress and inflammation....
6 months ago
Explore why official drug package inserts fail to reflect modern evidence for clozapine prescribing. Learn how legal standards of care, case law, slow titration, and vital adverse event monitoring empower clinicians to prioritize evidence-based medical practice over outdated manufacturer labeling.
Today
Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
